Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial.
Saved in:
| Title: | Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial. |
|---|---|
| Authors: | Blaye C; Department of Medical Oncology, Institut Bergonié, ImmunoConcEpT, CNRS 5164, Bordeaux, France., Bidard FC; Department of Medical Oncology, Institut Curie Paris et Saint Cloud, INSERM CIC1428, Université de Versailles-Saint-Quentin, Université Paris-Saclay, Saint Cloud, France., Hue L; Clinical and Epidemiological Research Unit, Institut Bergonié, Bordeaux, France., Howarth K; SAGA Diagnostics, Lund, Sweden., Pierga JY; Department of Medical Oncology, Institut Curie - Paris, Université Paris Cité, Paris, France., Dalenc F; Department of Medical Oncology, Oncopole Claudius Regaud, IUCT-Oncopole, Université de Toulouse, Toulouse, France., Jacot W; Department of Medical Oncology, Institut du cancer de Montpellier, INSERM U1194, Université de Montpellier, Montpellier, France., Djerroudi L; Department of Biopathology, Institut Curie - Paris, Paris, France., Potonnier W; Department of Biopathology, Institut Curie - Saint Cloud, France., Dumas V; Clinical and Epidemiological Research Unit, Institut Bergonié, Bordeaux, France., Lalet C; Clinical and Epidemiological Research Unit, Institut Bergonié, Bordeaux, France., Maréchal M; Department of Biopathology, Institut Bergonié, Bordeaux, France., Pulido M; Clinical and Epidemiological Research Unit, Institut Bergonié, INSERM CIC1401, Bordeaux, France., Brunet M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Salabert L; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Venat L; Department of Medical Oncology, CHU Limoges, Limoges, France., Maran-Gonzalez A; Department of Pathology, Institut du cancer de Montpellier, Montpellier, France., Saal LH; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden; Skåne University Hospital Comprehensive Cancer Centre, Lund, Sweden., Franchet C; Department of Biopathology, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France., Birkeälv S; SAGA Diagnostics, Lund, Sweden., MacGrogan G; Department of Biopathology, Institut Bergonié, INSERM U1312 BRIC, Bordeaux, France., Bonnefoi H; Department of Medical Oncology, Institut Bergonié, INSERM U1312 BRIC, Université de Bordeaux UFR Collège Sciences de la Santé, Bordeaux, France. Electronic address: h.bonnefoi@bordeaux.unicancer.fr. |
| Source: | ESMO open [ESMO Open] 2026 Jun; Vol. 11 (6), pp. 107766. Date of Electronic Publication: 2026 Jun 04. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42242004 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Blaye+C%22">Blaye C</searchLink>; Department of Medical Oncology, Institut Bergonié, ImmunoConcEpT, CNRS 5164, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Bidard+FC%22">Bidard FC</searchLink>; Department of Medical Oncology, Institut Curie Paris et Saint Cloud, INSERM CIC1428, Université de Versailles-Saint-Quentin, Université Paris-Saclay, Saint Cloud, France.<br /><searchLink fieldCode="AU" term="%22Hue+L%22">Hue L</searchLink>; Clinical and Epidemiological Research Unit, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Howarth+K%22">Howarth K</searchLink>; SAGA Diagnostics, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Pierga+JY%22">Pierga JY</searchLink>; Department of Medical Oncology, Institut Curie - Paris, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dalenc+F%22">Dalenc F</searchLink>; Department of Medical Oncology, Oncopole Claudius Regaud, IUCT-Oncopole, Université de Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Jacot+W%22">Jacot W</searchLink>; Department of Medical Oncology, Institut du cancer de Montpellier, INSERM U1194, Université de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Djerroudi+L%22">Djerroudi L</searchLink>; Department of Biopathology, Institut Curie - Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Potonnier+W%22">Potonnier W</searchLink>; Department of Biopathology, Institut Curie - Saint Cloud, France.<br /><searchLink fieldCode="AU" term="%22Dumas+V%22">Dumas V</searchLink>; Clinical and Epidemiological Research Unit, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Lalet+C%22">Lalet C</searchLink>; Clinical and Epidemiological Research Unit, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Maréchal+M%22">Maréchal M</searchLink>; Department of Biopathology, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Pulido+M%22">Pulido M</searchLink>; Clinical and Epidemiological Research Unit, Institut Bergonié, INSERM CIC1401, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Brunet+M%22">Brunet M</searchLink>; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Salabert+L%22">Salabert L</searchLink>; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Venat+L%22">Venat L</searchLink>; Department of Medical Oncology, CHU Limoges, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Maran-Gonzalez+A%22">Maran-Gonzalez A</searchLink>; Department of Pathology, Institut du cancer de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Saal+LH%22">Saal LH</searchLink>; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden; Skåne University Hospital Comprehensive Cancer Centre, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Franchet+C%22">Franchet C</searchLink>; Department of Biopathology, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Birkeälv+S%22">Birkeälv S</searchLink>; SAGA Diagnostics, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22MacGrogan+G%22">MacGrogan G</searchLink>; Department of Biopathology, Institut Bergonié, INSERM U1312 BRIC, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Bonnefoi+H%22">Bonnefoi H</searchLink>; Department of Medical Oncology, Institut Bergonié, INSERM U1312 BRIC, Université de Bordeaux UFR Collège Sciences de la Santé, Bordeaux, France. Electronic address: h.bonnefoi@bordeaux.unicancer.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2026 Jun; Vol. 11 (6), pp. 107766. <i>Date of Electronic Publication: </i>2026 Jun 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42242004 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.esmoop.2026.107766 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 107766 Titles: – TitleFull: Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Blaye C – PersonEntity: Name: NameFull: Bidard FC – PersonEntity: Name: NameFull: Hue L – PersonEntity: Name: NameFull: Howarth K – PersonEntity: Name: NameFull: Pierga JY – PersonEntity: Name: NameFull: Dalenc F – PersonEntity: Name: NameFull: Jacot W – PersonEntity: Name: NameFull: Djerroudi L – PersonEntity: Name: NameFull: Potonnier W – PersonEntity: Name: NameFull: Dumas V – PersonEntity: Name: NameFull: Lalet C – PersonEntity: Name: NameFull: Maréchal M – PersonEntity: Name: NameFull: Pulido M – PersonEntity: Name: NameFull: Brunet M – PersonEntity: Name: NameFull: Salabert L – PersonEntity: Name: NameFull: Venat L – PersonEntity: Name: NameFull: Maran-Gonzalez A – PersonEntity: Name: NameFull: Saal LH – PersonEntity: Name: NameFull: Franchet C – PersonEntity: Name: NameFull: Birkeälv S – PersonEntity: Name: NameFull: MacGrogan G – PersonEntity: Name: NameFull: Bonnefoi H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2059-7029 Numbering: – Type: volume Value: 11 – Type: issue Value: 6 Titles: – TitleFull: ESMO open Type: main |
| ResultId | 1 |
